本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Miragen Therapeutics, Inc.

23.01
0.0000
成交量:- -
成交額:- -
市值:8,992.67萬
市盈率:-2.38
高:23.01
開:23.01
低:23.01
收:23.01
52周最高:34.05
52周最低:4.67
股本:390.82萬
流通股本:317.21萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-9.6662
每股收益(LYR):-20.0436
淨資產收益率:-136.12%
總資產收益率:-48.09%
市淨率:4.27
市盈率(LYR):-1.15

資料載入中...

2021/07/26

重要事件披露

8-K - Current report
2021/07/15

重要事件披露

8-K - Current report
2021/06/15

重要事件披露

8-K/A [Amend] - Current report
2021/06/04

重要事件披露

8-K - Current report
2021/06/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/17

重要事件披露

8-K - Current report
2021/05/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/04/26

重要事件披露

8-K - Current report
2021/03/26

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/26

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/20

重要事件披露

8-K - Current report
2021/01/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals